Sign in

CIK 0000748592

  • Non-accelerated filer
  • Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
311103425
Phone
+1 617-798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-08-31 Bristol James Arthur Director Grant or award · Stock Option (Right to buy) +8,320 8,320
2026-08-31 Bristol James Arthur Director Grant or award · Stock Option (Right to buy) +5,083 5,083
2026-08-31 Cicala Peter Director Grant or award · Stock Option (Right to buy) +5,943 5,943
2026-08-31 Cicala Peter Director Grant or award · Stock Option (Right to buy) +5,083 5,083
2026-08-31 Polinsky David Director Grant or award · Stock Option (Right to buy) +5,083 5,083
2026-08-31 Wexler William A. Director Grant or award · Stock Option (Right to buy) +5,943 5,943
2026-08-31 Ratner Elena Director Grant or award · Stock Option (Right to buy) +5,944 5,944
2026-08-31 Luther Sanjeev President and CEO Grant or award · Stock Option (right to buy) +118,848 118,848
2026-02-10 Cherington Charles 10% owner Purchase +4,000,000 $0.50 $2.0M 6,779,440
2026-02-10 Cherington Charles 10% owner Purchase · Warrants to Purchase Common Stock +4,000,000 4,000,000
2025-06-21 Gurrola Sandra M Sr. VP of Finance Option exercise +30 110
2025-06-21 Gurrola Sandra M Sr. VP of Finance Option exercise · Restricted Stock Units +30 0
2025-06-09 Cherington Charles 10% owner Purchase +21,241,163 $0.10 $2.2M 41,659,743
2025-04-02 Cherington Charles 10% owner Purchase +3,768,397 $0.10 $394K 20,401,602
2025-02-07 Wexler William A. Director Grant or award · Stock Option (right to buy) +124,533 124,533
2025-02-07 Gurrola Sandra M Sr. VP of Finance Grant or award · Stock Option (Right to buy) +150,000 150,000
2025-02-07 Bristol James Arthur Director Grant or award · Stock Option (Right to buy) +72,074 72,074
2025-02-07 Cicala Peter Director Grant or award · Stock Option (Right to buy) +51,485 51,485
2025-02-07 Luther Sanjeev President & CEO Grant or award · Stock Option (right to buy) +1,123,350 1,123,350
2025-01-13 Ratner Elena Director Grant or award · Stock Option (Right to buy) +140,078 140,078

Page 1 of 37 · 737 trades